Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. Since its establishment in 1983 the company has been dedicated to improving the lives of patients. Octapharma was founded in 1983 on the fundamental principle of improving the lives of patients. Since then we have remained focused on our collective responsibility for the trust instilled in us by physicians and patients worldwide. In 2012, the Octapharma Board identified the core strategic pillars which will lead to the achievement of the organization’s ambitious long term goals.

Leukocare is a biotechnology company specialized in the field of biopharmaceutical formulation development. Operating at the interface of drug substance and drug product development, Leukocare combines sound knowledge of formulation development with bioinformatics and artificial intelligence.

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Guangxi Wuhe Boao Pharmaceutical Co., Ltd., established on 2014-08-20, Business scope includes medical technology development,transfer,Serve,consult;pharmaceutical production,operate;Production and operation of plant extracts;food,Healthy food,Production and operation of food additives;Cosmetics production and operation;business management,buisness planning;Building Construction,Construction General Contracting;graphic design.(Above business scope,All projects involving administrative licensing shall be operated within the validity period of the license,The specific projects are subject to the projects approved by the examination and approval department)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Beijing Wehand-Bio Pharmaceutical Co., Ltd. is a Chinese company located in Beijing. The firm manufactures pharmaceuticals. It was founded in 2010. Xiao Juan Wu is the current CEO of the firm.

J-Oil Mills, Inc. engages in the production, processing, and sale of fats and oil products. It operates through the following segments: Oils & Fats, Processed Products, Foodstuff & Fine Materials, and Others. The Oils & Fats segment supplies household and professional-use oils & fats, and oilseed meals. The Processed Products segment handles margarines, shortening, and powdered oils & fats. The Foodstuff & Fine Materials segment covers starch and chemical business promotions. The Others segment engages in the business of real estate leasing services. The company was founded on April 1, 2002 and is headquartered in Tokyo, Japan.

The Noguchi Institute is a research institute that conducts research and education to contribute to society as a public corporation.

Heartseed, Inc. engages in the provision of cardiac regenerative medicine. The company was founded by Keiichi Fukuda, Takumi Akiyama, Toshiharu Furukawa and Yutaro Kasai on November 30, 2015 and is headquartered in Tokyo, Japan.

Dushan County Junpeng Agricultural Products Co., Ltd., established on 2013-05-10, Business scope includes legal,regulations,Those prohibited by the State Council's decision shall not operate;law,regulations,The State Council has decided to allow(approval)of,After approval by the examination and approval authority(approval)file management;law,regulations,The State Council has decided that a license is not required(approval)of,Market entities independently choose to operate.(vegetable,horticultural crops,mushroom,fungus,Ganoderma lucidum planting,Sales;Ganoderma lucidum spore powder sales;Engage in the export business of self-operated products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).)

Cirqle Biomedical Contraception IVS engages in pre-clinical development of a novel non-hormonal contraceptive technology. It has developed a technology that leverages the natural barrier properties of cervical mucus. The company was founded by Frederik Petursson Madsen, Thomas Crouzier and Ljudmila Katchan in 2018 and is headquartered in Copenhagen, Denmark.

Yakult Honsha Co., Ltd. engages in the manufacture and sale of food and beverage products, cosmetics, and pharmaceuticals. It operates through the following segments: Food and Beverages in Japan, the Americas, Asia and Oceania, and Europe; Pharmaceuticals, and Others. The Food and Beverages segment produces and merchandises milk drinks, noodles, juices, and soft drinks. The Pharmaceuticals segment manufactures and sells anti-cancer drugs and other pharmaceutical products. The Others segment includes cosmetics and professional baseball team management. The company was founded by Minoru Shirota in 1935 and is headquartered in Tokyo, Japan.

Engages in developing, producing and selling pharmaceutical and chemical products

MorphoSys AG is a therapeutic antibody company based in Martinsried, Germany. The company claims to have more than 100 drugs in its wider pipeline, being investigated for the treatment of cancer, Alzheimer's disease, infectious diseases, cardiovascular dysfunction, and inflammation. While many of these are being developed in partnership with pharma and biotech companies, MorphoSys also maintains an internal pipeline with antibodies in preclinical and clinical development.

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

MORITEX Corp. engages in the manufacture and sale of applied optical equipment and functional materials. It operates through the following segments: Machine Vision Systems and Industrial Business, Cosmetics and Medical Instruments Business, and Functional Materials and Other Business. The company was founded in February 1973 and is headquartered in Tokyo, Japan.

Guizhou Jisheng Agricultural Technology Co., Ltd., established on 2014-08-21, Business scope includes legal,regulations,Those prohibited by the State Council's decision shall not operate;law,regulations,The State Council has decided to allow(approval)of,After approval by the examination and approval authority(approval)file management;law,regulations,The State Council has decided that a license is not required(approval)of,Market entities independently choose to operate.(Agricultural technology extension service;Agricultural tourism project development;vegetable,flowers,fruit,Chinese herbal medicine(Except for state exclusive control)to plant;aquaculture;Primary Agricultural Sales;Engage in the import and export of goods or technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).)

Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France.

Glyconix Corp. manufactures anti infective and oncology drugs. The company was founded by Ivan Kanevski and is headquartered in New York, NY.

Sichuan Mingtong Tianxia Tea Co., Ltd., established on 2020-12-23, Business scope includes general items:tea planting;Tea set sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Conference and Exhibition Services;Domestic trade agent(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:food business(Selling prepackaged food);Food Internet Sales(Selling prepackaged food);travel business;commercial performance;Import and export;Technology Import and Export;Catering Services(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).